Integris Healthcare, a global diversified medical technology (MedTech) company, announced the appointment of Probir Das as Chief Executive Officer (CEO).
Das will join effective November 2024 and will be based in New Delhi, India. With over three decades of global MedTech experience, he will lead the next phase of growth and innovation for the Company. Probir joins Integris from Terumo Asia Pacific, where he served as Chairman & Managing Director since 2019.
Avnish Mehra, Vice Chairman – Everstone Capital, said, “Probir’s exceptional track record of scaling businesses at Terumo both in India and in Southeast Asia, combined with his years of experience in India at Becton Dickenson and at Boston Scientific make him the ideal leader to take Integris to new heights.”
“I have seen Probir scaling many businesses in the last 25 years with his deep understanding of MedTech markets. He is an inspiring leader who creates a culture of collaboration and accountability empowering teams to exceed their goals. He is highly regarded for his adaptability and commitment to sustainable growth,” said Gurmit Chugh, Co-founder of Integris.
Probir Das said, “Throughout my career, I have focused on driving innovation, establishing new therapies, and fostering rapid growth in the MedTech sector. Together with Integris’ talented team, I look forward to expanding our market presence, delivering cutting-edge medical technologies to patients worldwide, and ultimately transforming healthcare delivery on a global scale.”
